(Q40604184)

22 September 2017

title

Balance between interleukin-10 and interleukin-12 in adult cancer patients with or without infections (English)

1 reference

22 September 2017

Kallio R

1

1 reference

22 September 2017

Surcel HM

series ordinal

2

1 reference

22 September 2017

Bloigu A

series ordinal

3

1 reference

22 September 2017

Syrjälä H

series ordinal

4

1 reference

22 September 2017

publication date

1 May 2001

1 reference

European Journal of Cancer

22 September 2017

published in

1 reference

22 September 2017

volume

37

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

857-861

1 reference

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Cytokine production in children with tuberculous infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Basic principles of ROC analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Index for rating diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Procalcitonin--a new indicator of the systemic response to severe infections

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

Prostaglandin E(1) protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900016-8

7 January 2021

10.1016/S0959-8049(01)00016-8

Identifiers

DOI

1 reference

22 September 2017

1 reference